A low circulating level of adiponectin contributes to the pathogenesis of metabolic syndrome, acts as a risk factor for type 2 diabetes mellitus, and plays a role in the development of cardiovascular disease caused by abdominal obesity and insulin resistance [4], [5]. The gene discussed is ADIPOQ; the disease is type 2 diabetes mellitus.